Status:
UNKNOWN
Screening and Early Warning of Chronic Obstructive Pulmonary Disease Combined With Sleep Respiratory Disease Based on Medical Internet of Things
Lead Sponsor:
Peking University Third Hospital
Collaborating Sponsors:
Beijing Municipal Health Commission
BOE Technology Group Co. Ltd.
Conditions:
COPD
Osa Syndrome
Eligibility:
All Genders
40-80 years
Brief Summary
Chronic obstructive pulmonary disease (COPD) is a common disease that endangers people's health, causing severe economic and treatment burdens. Sleep breathing disease, as a complication of COPD, incr...
Detailed Description
This study is a multi-center joint study, which mainly consists of two parts. First, a cross-sectional observational study was adopted to recruit patients with stable COPD in multiple centers. The COP...
Eligibility Criteria
Inclusion
- The diagnostic criteria for COPD are in line with the diagnostic guidelines for COPD in China from 40 to 80 years old.
Exclusion
- Patients who cannot use IoT's mobile applications and cannot complete sleep monitoring and follow-up visits.
Key Trial Info
Start Date :
January 1 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2022
Estimated Enrollment :
680 Patients enrolled
Trial Details
Trial ID
NCT04833725
Start Date
January 1 2020
End Date
December 31 2022
Last Update
April 6 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Peking University Third Hospital
Beijing, China